C-reactive protein-induced production of interleukin-18 in human endothelial cells: A mechanism of orchestrating cytokine cascade in acute coronary syndrome

Heart and Vessels

Volumn 18, Issue 4, 2003, Pages 183-187

  Yamaoka Tojo, Minako ^a,b   Tojo, Taiki ^a   Masuda, Takashi ^a   Machida, Yoji ^a   Kitano, Yoshikazu ^a   Kurosawa, Toshirou ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndrome; C reactive protein; Interleukin 18

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 18; RECOMBINANT PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; UNSTABLE ANGINA PECTORIS; UPREGULATION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-18; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN;

EID: 0141961884     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-003-0719-7     Document Type: Article

References (23)

1. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
2. Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165-2168
3. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Haruka A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Alita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto Y (1995) Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91
4. Tsutsui H, Nanishi K, Katsui K, Higashino K, Okamura H, Miyazaki Y, Kaneda K (1996) IFN-gamma-inducing factor upregulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 157:3967-3973
5. Gracia JA, Forsey RJ, Chan WL, Glimour A, Leung BP, Greer MR, Kennedy K, Carter R, Wei X-Q, Xu D, Field M, Foulis A, Liew FY, McInnes IB (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104:1393-1401
6. Shigehara K, Shijubo N, Ohmichi M, Yamada G, Takahashi R, Okamura H, Kurimoto M, Hiraga Y, Tatsuno T, Abe S, Sato N (2000) Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 162:1979-1982
7. Kanda T, Tanaka T, Sekiguchi K, Seta Y, Kurimoto M, Wilson McManus JE, Nagai R, Yang D, McManus BM, Kobayashi I (2000) Effect of interleukin-18 on viral myocarditis: enhancement of interferon-gamma and natural killer cell activity. J Mol Cell Cardiol 32:2163-2171
8. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A (2001) Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104:1598-1603
9. Mallat Z, Henry P, Fressonnet R, Scoazec A, Chvatchko Y, Tedgui A (2001) Plasma levels of interleukin (IL)-18 are increased in patients with acute coronary syndromes and are associated with increased mortality at follow-up. Circulation 104:II-390
10. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ (2002) Interleukin-18 is a strong predictor of cardiovasucular death in stable and unstable angina. Circulation 106:24-30
11. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U (2002) Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 195:245-257
12. Seta Y, Kanda T, Tanaka T, Arai M, Sekiguchi K, Yokoyama T, Kurimoto M, Tamura J, Kurabayashi M (2000) Interleukin 18 in acute myocardial infarction. Heart 84:668
13. Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman M, Mahaffey KW, Newby LK, Califf RM, Simoons ML, Topol EJ, Lauer MS (2002) Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 346:2047-2052
14. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR (2002) Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 39:1917-1923
15. Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A (2001) Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 89:e41-e45
16. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220
17. Fiorentino DF, Zlotnik A, Mossman TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822
18. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Espoisito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85:e17-e24
19. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC (2001) Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104:746-749
20. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331:417-424
21. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979
22. Shah PK (2000) Circulating markers of inflammation for vascular risk prediction: are they ready for prime time? Circulation 101: 1758-1759
23. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE (1999) C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 100:96-102